DAVIS A BRIAN — SEC insider filings

SEC reporting owner CIK 1184432. 7 insider filings on record with FilingPulse; latest filed 2026-09-21.

Transaction summary — filings shown

Covers all 7 filings on record, filed 2020-08-17 to 2026-09-21. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Verrica Pharmaceuticals Inc. (VRCA)Chief Financial Officer32 legs · 12,900 sh · $98,746—1
Grace Therapeutics, Inc. (GRCE)Director4——4

Insider filings — DAVIS A BRIAN

FiledFormIssuerReported transactionsSource
2026-09-214Grace Therapeutics, Inc. (GRCE)Grant/award (A) @ $0EDGAR
2026-01-124Grace Therapeutics, Inc. (GRCE)Grant/award (A): 10,000 (derivative) @ $0EDGAR
2025-05-134Grace Therapeutics, Inc. (GRCE)Grant/award (A): 10,000 (derivative) @ $0EDGAR
2023-12-204Acasti Pharma Inc. (ACST)Grant/award (A): 22,500 (derivative) @ $0EDGAR
2021-06-074Verrica Pharmaceuticals Inc. (VRCA)Purchase (P): 5,000 @ $9.89EDGAR
2021-03-034Verrica Pharmaceuticals Inc. (VRCA)Grant/award (A): 65,000 (derivative) @ $0EDGAR
2020-08-174Verrica Pharmaceuticals Inc. (VRCA)Purchase (P): 7,900 @ $6.24EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-08-10 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1184432 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs